CRISPR/Cas9 and gene therapy
The development of techniques that allow the precise and efficient edition of the genome of living cells is one of the main goals of biomedical research. Over the last few decades, a number of genome editing tools have been developed, the most prominent being the CRISPR/Cas9 system, a bacterial defe...
Guardado en:
Publicado: |
2017
|
---|---|
Materias: | |
Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v77_n5_p405_Giono http://hdl.handle.net/20.500.12110/paper_00257680_v77_n5_p405_Giono |
Aporte de: |
id |
paper:paper_00257680_v77_n5_p405_Giono |
---|---|
record_format |
dspace |
spelling |
paper:paper_00257680_v77_n5_p405_Giono2025-07-30T17:35:30Z CRISPR/Cas9 and gene therapy CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing The development of techniques that allow the precise and efficient edition of the genome of living cells is one of the main goals of biomedical research. Over the last few decades, a number of genome editing tools have been developed, the most prominent being the CRISPR/Cas9 system, a bacterial defense mechanism that has been redesigned for its use in other cellular systems. The accessibility, both technical and economical, and the enormous potential of CRISPR/Cas9 have contributed to an almost unprecedented revolution in the biomedical sciences and represent an important step forward in the field of gene therapy that needs, however, to be taken cautiously. 2017 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v77_n5_p405_Giono http://hdl.handle.net/20.500.12110/paper_00257680_v77_n5_p405_Giono |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing |
spellingShingle |
CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing CRISPR/Cas9 and gene therapy |
topic_facet |
CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing |
description |
The development of techniques that allow the precise and efficient edition of the genome of living cells is one of the main goals of biomedical research. Over the last few decades, a number of genome editing tools have been developed, the most prominent being the CRISPR/Cas9 system, a bacterial defense mechanism that has been redesigned for its use in other cellular systems. The accessibility, both technical and economical, and the enormous potential of CRISPR/Cas9 have contributed to an almost unprecedented revolution in the biomedical sciences and represent an important step forward in the field of gene therapy that needs, however, to be taken cautiously. |
title |
CRISPR/Cas9 and gene therapy |
title_short |
CRISPR/Cas9 and gene therapy |
title_full |
CRISPR/Cas9 and gene therapy |
title_fullStr |
CRISPR/Cas9 and gene therapy |
title_full_unstemmed |
CRISPR/Cas9 and gene therapy |
title_sort |
crispr/cas9 and gene therapy |
publishDate |
2017 |
url |
https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v77_n5_p405_Giono http://hdl.handle.net/20.500.12110/paper_00257680_v77_n5_p405_Giono |
_version_ |
1840327649061240832 |